European Association of E-Pharmacies (EAEP): EAEP as a Driving Force and Think Tank: European Association of Online Pharmacies Repositions Itself
23.2.2021 09:00:00 CET | news aktuell GmbH | Press release
(Brussels/Berlin): – The leading association of European online pharmacies has a new board team, a new name and a new external image:
Walter Hess, Head Germany in the Group Management of the Zur Rose Group and CEO of DocMorris N.V., is now president of the association and Stefan Feltens, CEO SHOP APOTHEKE EUROPE, is vice president and secretary general. With the new leadership duo, the association of online pharmacies will shape the European healthcare sector’s digital transformation in a future-oriented way. A key goal is to further expand the practical patient benefits of online pharmacies in the implementation of future e-health concepts. Vladimir Finsterle, CEO and founder of Pearls Health Cyber s.r.o., and Gianni De Gaspari, CEO and co-founder of the online pharmacy Viata, complete the board.
By changing its name from EAMSP (European Association of Mail Service Pharmacies) to EAEP (European Association of E-Pharmacies), the association underlines its key role in Europe’s increasingly digitised healthcare systems. As online pharmacies, the EAEP’s long-standing members ensure that people all over Europe have optimal access to medicines and pharmaceutical advice every single day. Accordingly, the new logo symbolises the connection between people and pharmacies.
"With Walter Hess, the EAEP gains an experienced market expert as president," says Stefan Feltens. "Together we will demonstrate that the members of the EAEP have systemically relevant answers to changing customer needs and market conditions. To ensure this, we will continue and further intensify our dialogue with politics, society and the economy. We see ourselves as a driving force and use our digital skills for the benefit of consumers.
"As a leadership duo, we want to help shape the future of the healthcare system. We see the EAEP as a European think tank for e-health issues. As pioneers in the European pharmacy market, we will leverage digital solutions to contribute to advancing access, safety, quality, service and sustainability in healthcare in the interest of consumers across Europe," emphasises Walter Hess.
The new website www.eaep.com gives the association a contemporary web presence that describes its services and positions and provides a wide range of information on the European health market, from statements on legislation to electronic prescriptions.
Profile: The European Association of E-Pharmacies (EAEP) represents the interests of its members and protects the needs of its members' patients and customers. It informs the public in a transparent manner, enters into a dialogue with politics, the economy and market partners, and contributes its concepts to strengthen the European health sector and to enable cost reductions through digitisation.
The members of the EAEP are pioneers in digital solutions designed to continuously improve the quality, safety and efficiency of healthcare for people across Europe. The association bundles the voices of its members in position papers and promotes interaction and knowledge exchange.
Contacts
EAEP
Avenue Marnix 28
B-1000 Ixelles / Brussels
Belgium
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:52:44 CEST | Press release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Democracy News Alliance: Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:55:20 CEST | Press release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found.
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 13:06:01 CEST | Press release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 10:17:49 CEST | Press release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom

